Non-CME/CE
Women's Health
Overview
In this session, we will review an FDA-approved treatment for moderate to severe vasomotor symptoms due to menopause, including indication, mechanism of action, and clinical safety and efficacy.
SPONSORED BY
Astellas Pharma US, Inc.